EVIO Inc
EVIO, Inc. provides analytical testing and advisory services to the cannabis industry. It also offers residential and commercial construction services. The company was incorporated in 1977 and is based in Henderson, Nevada.
EVIO Inc (EVIO) - Net Assets
Latest net assets as of December 2022: $-12.50 Million USD
Based on the latest financial reports, EVIO Inc (EVIO) has net assets worth $-12.50 Million USD as of December 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($953.00K) and total liabilities ($13.45 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-12.50 Million |
| % of Total Assets | -1311.54% |
| Annual Growth Rate | N/A |
| 5-Year Change | -414.2% |
| 10-Year Change | N/A |
| Growth Volatility | 843.26 |
EVIO Inc - Net Assets Trend (2015–2022)
This chart illustrates how EVIO Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EVIO Inc (2015–2022)
The table below shows the annual net assets of EVIO Inc from 2015 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-09-30 | $-12.39 Million | +14.55% |
| 2021-09-30 | $-14.50 Million | +11.38% |
| 2020-09-30 | $-16.36 Million | -514.95% |
| 2019-09-30 | $3.94 Million | 0.00% |
| 2018-09-30 | $3.94 Million | +1648.90% |
| 2017-09-30 | $225.44K | +155.39% |
| 2016-09-30 | $-407.00K | -242.66% |
| 2015-09-30 | $285.29K | -- |
Equity Component Analysis
This analysis shows how different components contribute to EVIO Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4883137700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.66 Million | % |
| Other Comprehensive Income | $-76.00K | % |
| Other Components | $34.56 Million | % |
| Total Equity | $-12.74 Million | 100.00% |
EVIO Inc Competitors by Market Cap
The table below lists competitors of EVIO Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
VOGO S.A. EO-125
F:7CY
|
$1.01 Million |
|
CWTH BK AUSTRALIA
MU:CWW
|
$1.01 Million |
|
LYXOR Index Fund - Lyxor Smart Overnight Return
F:EGV2
|
$1.01 Million |
|
WISCONSIN ENERGY - Dusseldorf Stock Exchang
DU:WIC
|
$1.01 Million |
|
XSLR
F:XSLR
|
$1.01 Million |
|
Identa Corp
OTCQB:IDTA
|
$1.01 Million |
|
Wirecard AG
PINK:WRCDF
|
$1.01 Million |
|
RangDong Plastic JSC
VN:RDP
|
$1.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EVIO Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from -14,204,000 to -12,744,000, a change of 1,460,000.
- Net income of 48,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 70,000.
- Other factors increased equity by 1,342,000.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $48.00K | +0.38% |
| Other Comprehensive Income | $70.00K | +0.55% |
| Other Changes | $1.34 Million | +10.53% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares EVIO Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-09-30 | $-0.02 | $0.00 | x |
| 2015-09-30 | $0.06 | $0.00 | x |
| 2016-09-30 | $-0.12 | $0.00 | x |
| 2017-09-30 | $0.01 | $0.00 | x |
| 2018-09-30 | $0.09 | $0.00 | x |
| 2019-09-30 | $0.12 | $0.00 | x |
| 2020-09-30 | $-0.23 | $0.00 | x |
| 2021-09-30 | $-0.01 | $0.00 | x |
| 2022-09-30 | $-0.01 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EVIO Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.02%
- • Asset Turnover: 1.21x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-802.20%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-637.85K |
| 2015 | -772.36% | -1160.83% | 0.17x | 3.87x | $-1.47 Million |
| 2016 | 0.00% | -450.16% | 0.26x | 0.00x | $-2.47 Million |
| 2017 | -5288.70% | -117.85% | 0.50x | 89.40x | $-3.57 Million |
| 2018 | -579.36% | -345.68% | 0.23x | 7.15x | $-11.83 Million |
| 2019 | -579.36% | -345.68% | 0.23x | 7.15x | $-11.83 Million |
| 2020 | 0.00% | -234.01% | 0.46x | 0.00x | $-6.78 Million |
| 2021 | 0.00% | -40.84% | 0.45x | 0.00x | $455.40K |
| 2022 | 0.00% | 3.02% | 1.21x | 0.00x | $1.32 Million |
Industry Comparison
This section compares EVIO Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EVIO Inc (EVIO) | $-12.50 Million | 0.00% | N/A | $1.01 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |